Regeneron Pharmaceuticals (REGN) operating margin

Operating margin · fiscal 2025
25.8%

Regeneron Pharmaceuticals (REGN) had an operating margin of 25.8% in fiscal 2025 (the year ended December 31, 2025). That is 2.3 percentage points lower than the 28.1% of fiscal 2024. Figures as of 17 Nov 2026, 23:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
25.8%
Change on fiscal 2024
−2.3 pts
Highest on record
55.7%fiscal 2021
Lowest on record
-46.0%fiscal 2011
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Regeneron Pharmaceuticals operating margin, in more detail

Across the 18 fiscal years on record (2008–2025), the highest was 55.7% in fiscal 2021 and the lowest -46.0% in fiscal 2011. The fiscal 2025 figure is higher than in 24% of the 17 earlier fiscal years on record, whose median is 30.9%.

Gross margin was 85.4% in fiscal 2025. Net margin was 31.4% in fiscal 2025.

History · 18 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Regeneron Pharmaceuticals operating margin, year by year

Regeneron Pharmaceuticals (REGN) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
202525.8% 2.3 pts down85.4%31.4%
202428.1% 2.8 pts down86.1%31.1%
202330.9% 8.1 pts down86.2%30.1%
202238.9% 16.7 pts down87.2%35.6%
202155.7% 13.6 pts up—50.2%
202042.1% 8.4 pts up—41.3%
201933.7% 15.6 pts down—32.3%
201849.3% 13.8 pts up—47.5%
201735.4% 8.0 pts up—20.4%
201627.4% 3.1 pts down—18.4%
201530.5% 1.3 pts up—15.5%
201429.2% 6.1 pts down—12.0%
201335.3% 2.1 pts up—19.7%
201233.2% 79.2 pts up—54.4%
2011-46.0% 24.8 pts down—-49.7%
2010-21.2% 1.7 pts down—-22.8%
2009-19.5% 16.6 pts up—-17.9%
2008-36.2%——-33.2%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Regeneron Pharmaceuticals and comparable companies
CompanyOperating marginFiscal year
Moderna MRNA-159.9%2025
CVS Health CVS2.6%2025
HCA Healthcare HCA15.8%2025
GSK GSK25.5%2025
Regeneron Pharmaceuticals REGN25.8%2025
Elevance Health ELV5.5%2021

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on REGN

Regeneron Pharmaceuticals, figure by figure

Regeneron Pharmaceuticals (REGN) overview: price, valuation and scorecardAll health care companies by market value

Regeneron Pharmaceuticals operating margin: questions and answers

What is Regeneron Pharmaceuticals's operating margin?

Regeneron Pharmaceuticals (REGN) had an operating margin of 25.8% in fiscal 2025 (the year ended December 31, 2025). That is 2.3 percentage points lower than the 28.1% of fiscal 2024.

Is Regeneron Pharmaceuticals's operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 24% of the 17 earlier fiscal years on record, whose median is 30.9%.

What are the highest and lowest operating margin figures on record for Regeneron Pharmaceuticals?

Across the 18 fiscal years on record (2008–2025), the highest was 55.7% in fiscal 2021 and the lowest -46.0% in fiscal 2011.

What are Regeneron Pharmaceuticals's gross and net margins?

Gross margin was 85.4% in fiscal 2025. Net margin was 31.4% in fiscal 2025.

How is Regeneron Pharmaceuticals's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Regeneron Pharmaceuticals (REGN) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/REGN/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.